These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2053117)

  • 1. Highly specific radioimmunoassay for digoxin using a monoclonal antibody selected for lack of interference by digoxin-like immunoreactive substances in cord blood sera.
    Wahyono D; Piechaczyk M; Scherrmann JM; Girard C; Grenier J; Mani JC; Bastide JM; Pau B
    Ther Drug Monit; 1991 Mar; 13(2):113-9. PubMed ID: 2053117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of digoxin in serum using monoclonal antibodies and assessment of interference by digoxin-like immunoreactive substances.
    Loucari-Yiannakou E; Yiannakou L; Souvatzoglou A; Diamandis EP
    Ther Drug Monit; 1990 Mar; 12(2):195-200. PubMed ID: 2315977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity of endogenous digitalis-like substances in cord blood sera studied with antidigitoxin monoclonal antibodies.
    Sandré C; Géniteau-Legendre M; Scherrmann JM; Quéro AM; Labarre C
    Ther Drug Monit; 1995 Feb; 17(1):19-24. PubMed ID: 7725372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of assay conditions on cross reactivity of digoxin-like immunoreactive substance(s) with radioimmunoassay kits.
    Pudek MR; Seccombe DW; Jacobson BE; Humphries K
    Clin Chem; 1985 Nov; 31(11):1806-10. PubMed ID: 4053349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin- and digitoxin-like immunoreactive substances in amniotic fluid, cord blood, and serum of neonates.
    Ebara H; Suzuki S; Nagashima K; Koizumi T; Nishida A; Kanbe Y; Kuroume T
    Pediatr Res; 1986 Jan; 20(1):28-31. PubMed ID: 3511439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digitoxinlike and digoxinlike immunoreactivitis in sera of patients with uremia and liver disease as measured by fluorescence polarization immunoassays: poor correlation between digitoxinlike and digoxinlike immunoreactivities.
    Luke M; Dasgupta A
    Ther Drug Monit; 1997 Apr; 19(2):230-5. PubMed ID: 9108656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of incubation time and temperature on the interference of digoxin-like immunoreactive substances in digoxin immunoassays.
    Yannakou L; Diamandis EP; Souvatzoglou A
    Ther Drug Monit; 1987 Dec; 9(4):461-3. PubMed ID: 3424414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufalin radioimmunoassays: in search of the endogenous digitalis-like substance.
    Panesar NS
    J Immunoassay; 1994 Nov; 15(4):371-91. PubMed ID: 7836543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel anti-digoxin monoclonal antibodies with different binding specificities for digoxin metabolites and other glycosides.
    Wahyono D; Piechaczyk M; Mourton C; Bastide JM; Pau B
    Hybridoma; 1990 Dec; 9(6):619-29. PubMed ID: 2076899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous digitalis-like immunoreactive substances in cord serum characterized by anti-digitoxin and anti-digoxin antibodies. Effect of modulated incubation conditions.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Biochem; 1986 Aug; 19(4):201-4. PubMed ID: 3530526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
    Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
    Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations.
    Dasgupta A; Trejo O
    Am J Clin Pathol; 1999 Mar; 111(3):406-10. PubMed ID: 10078117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor].
    Gawaz MP; Schreiber R; Vogt W; Genz T; Kellner M
    Klin Padiatr; 1990; 202(1):31-6. PubMed ID: 2156105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economical modification of a radioimmunoassay of digoxin with negligible interference from cord and neonatal sera.
    Lee HS; Yeoh TS; Lee AS; Ho NK; Ti TY
    Ther Drug Monit; 1986; 8(3):377-9. PubMed ID: 3750379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of four digoxin immunoassays with respect to interference from digoxin-like immunoreactive factors.
    Datta P; Hinz V; Klee G
    Clin Biochem; 1996 Dec; 29(6):541-7. PubMed ID: 8939401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined liquid chromatography/radioimmunoassay with improved specificity for serum digoxin.
    Gault MH; Longerich L; Dawe M; Vasdev SC
    Clin Chem; 1985 Aug; 31(8):1272-7. PubMed ID: 4017230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin-like immunoreactivity in cord blood plasma extracts is not only due to endogenous corticosteroids.
    Yiannakou L; Loucari-Yiannakou E; Souvatzoglou A
    Clin Biochem; 1991 Dec; 24(6):475-82. PubMed ID: 1773487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.